Bullish
IDEAYA Biosciences closes $345M public offering
IDEAYA Biosciences (NASDAQ: IDYA) has completed an underwritten public offering, raising approximately $345 million in gross proceeds. The offering in...
Bullish
IDEAYA Biosciences (NASDAQ: IDYA) has completed an underwritten public offering, raising approximately $345 million in gross proceeds. The offering in...
Ideaya Biosciences (IDYA) has formed a clinical partnership with Roche to study the safety and efficacy of IDE892 in combination with Roche’s pan-RAS ...